Celerion transforms the consent experience for sites and patients with veeva econsent

Pleasanton, calif., oct. 6, 2021 /prnewswire/ -- veeva systems (nyse: veev) today announced that celerion adopted veeva econsent, a myveeva for patients solution, to complete electronic consent for its phase i clinical trials.
VEEV Ratings Summary
VEEV Quant Ranking